69% Being on an e�ective treatment,

independent of the stage of disease

How involved are patients in the treatment decision-making process?

What is the most important aspect of living with IPF?

64% of patients said they were involved

30% of patients said they were not involved

6% do not know

INSIGHTS INTO IPF

PATIENT AND PHYSICIAN TREATMENT DISCUSSIONS AND PRIORITIES

What are the top 3 treatment priorities?

Knowing what treatment options are available

A top priority for 74% of patients*

Believed by 77% of physicians** to be a top patient priority

For more information on IPF and the survey results please visit www.lifewithipf.com*Data on file. Boehringer Ingelheim. Think of Everything Global Patient Survey. 2016. Global survey of 152 patients from 9 countries to gain their insights on idiopathic pulmonary fibrosis (IPF)**Data on file. Boehringer Ingelheim. Think of Everything Global Pulmonologist Survey. 2015. Results from this patient survey have been compared with results from a 2015 global survey of over 400 pulmonologists; Responses from pulmonologists when asked what they believed their patients’ priorities were

Of the 64% of patients who said they were involved when agreeing on an appropriate treatment…

58% Maintaining lung function for as long as possible

14% Reducing the risk of sudden worsening of my condition

12% Being on a medication withmanageable side-e�ects

PATIENT VIEWS*

29% only had a brief discussion with their doctor

PHYSICIAN VIEWS ON PATIENT

PR

IOR

ITIES**

83% Being on a treatment that allows me to continue my

day-to-day activities

67% Maintaining lung

function for as long as possible said further discussion

was not needed and they preferred to strictly follow their doctor's recommendation

30%

40%were actively involved in open discussions with their doctor